Lisa Rodgers

489 total citations
18 papers, 304 citations indexed

About

Lisa Rodgers is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Lisa Rodgers has authored 18 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Economics and Econometrics. Recurrent topics in Lisa Rodgers's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Genetic factors in colorectal cancer (2 papers). Lisa Rodgers is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Genetic factors in colorectal cancer (2 papers). Lisa Rodgers collaborates with scholars based in United Kingdom, United States and Australia. Lisa Rodgers's co-authors include John D. Wark, B Kaymakci, John L. Hopper, Benjamin L. Makepeace, A. J. Trees, Edwin van Wijngaarden, Susan Hyman, Richard Lowry, Charlotte M. Druschel and Caroline I. Magyar and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lisa Rodgers

13 papers receiving 296 citations

Peers

Lisa Rodgers

OSM

ONCOL

GENET

PHEOH

Griet Vanbillemont Belgium

Monica Grover United States

Lalita Wattanachanya Thailand

Gautam Khastgir United Kingdom

Martin Birkhæuser Switzerland

Zaynab Alourfi Syria

Bin Moore Australia

Dalal Bubshait Saudi Arabia

Leon Aravantinos Greece

Sarah Yagerman United States

Griet Vanbillemont Belgium

Lisa Rodgers

155 ×1.2

OSM

118 ×1.2

49 ×0.8

ONCOL

43 ×0.7

GENET

28 ×0.6

PHEOH

Citations per year, relative to Lisa Rodgers Lisa Rodgers (= 1×) peers Griet Vanbillemont

Countries citing papers authored by Lisa Rodgers

Since Specialization

Citations

This map shows the geographic impact of Lisa Rodgers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Rodgers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Rodgers more than expected).

Fields of papers citing papers by Lisa Rodgers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Rodgers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Rodgers. The network helps show where Lisa Rodgers may publish in the future.

Co-authorship network of co-authors of Lisa Rodgers

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Rodgers. A scholar is included among the top collaborators of Lisa Rodgers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Rodgers. Lisa Rodgers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Cartwright, Douglas, Alistair S. McLaren, Mark White, et al.. (2025). 109P Neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer: The west of Scotland experience. Annals of Oncology. 36. S50–S51.

Rodgers, Lisa. (2025). Amid Decreasing Infant Mortality, Sleep-Related Infant Deaths Are on the Rise. JAMA. 333(15). 1282–1282.

Baxter, Mark, Michael Rowe, Deborah J. Scott, et al.. (2024). UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study. SHILAP Revista de lepidopterología. 3(1). e000459–e000459. 2 indexed citations

Dearden, Helen Clare, Michael Rowe, Deborah J. Scott, et al.. (2024). A United Kingdom prospective, multicentre, observational cohort study investigating tolerance of anti-cancer systemic therapy in the elderly: The TOASTIE study.. Journal of Clinical Oncology. 42(16_suppl). 1521–1521.

Patel, Rachana, Catriona A. Ford, Lisa Rodgers, et al.. (2022). Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression. Cancer Research. 82(14). 2565–2575. 20 indexed citations

Olsson‐Brown, Anna, Mark Baxter, Laura Feeney, et al.. (2022). The association of pre-existing autoimmune disease and immune-related adverse events secondary to immune checkpoint inhibition therapy in a UK multicenter cohort.. Journal of Clinical Oncology. 40(16_suppl). 2522–2522.

Ghaus, Aisha, et al.. (2022). Real-world experience of pembrolizumab in microsatellite instability-high CRC: A Scottish multicenter analysis.. Journal of Clinical Oncology. 40(4_suppl). 54–54.

Coveler, Andrew L., Farasat Kazmi, Kristen K. Ciombor, et al.. (2021). A phase Ib study of NUC-3373 in combination with standard therapies in advanced/metastatic colorectal cancer (NuTide:302).. Journal of Clinical Oncology. 39(3_suppl). 93–93. 4 indexed citations

Olsson‐Brown, Anna, Mark Baxter, Caroline Dobeson, et al.. (2021). Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.. Journal of Clinical Oncology. 39(15_suppl). 12026–12026. 5 indexed citations

10.

Graham, Janet, Kristen K. Ciombor, Francesca Aroldi, et al.. (2020). 464P Pharmacokinetic analysis of NUC-3373 with and without leucovorin in patients with previously treated metastatic colorectal cancer (NuTide:302 study). Annals of Oncology. 31. S438–S439. 1 indexed citations

11.

Olsson‐Brown, Anna, Mark Baxter, Caroline Dobeson, et al.. (2020). Real-world outcomes of immune-related adverse events in 2,125 patients managed with immunotherapy: A United Kingdom multicenter series.. Journal of Clinical Oncology. 38(15_suppl). 7065–7065. 6 indexed citations

12.

Blagden, Sarah P., Janet S. Graham, Kristen K. Ciombor, et al.. (2019). Abstract C059: Inhibition of thymidylate synthase by the ProTide NUC-3373: in vitro analysis and clinical validation. Molecular Cancer Therapeutics. 18(12_Supplement). C059–C059. 1 indexed citations

13.

Lonergan, Mike, Anderson P. Jones, Lisa Rodgers, et al.. (2015). Patient characteristics influence treatment response to second line glucose lowering therapy in two large UK cohorts: a MASTERMIND study. Diabetic Medicine. 32. 2–2. 4 indexed citations

14.

Roizen, Nancy, Caroline I. Magyar, Emily S. Kuschner, et al.. (2013). A Community Cross-Sectional Survey of Medical Problems in 440 Children with Down Syndrome in New York State. The Journal of Pediatrics. 164(4). 871–875. 64 indexed citations

15.

Bradley, William H., et al.. (2007). Endometrial carcinoma expresses an increased cathepsin B/D ratio. Gynecologic Oncology. 108(1). 84–89. 8 indexed citations

16.

Makepeace, Benjamin L., Lisa Rodgers, & A. J. Trees. (2006). Rate of Elimination of Wolbachia pipientis by Doxycycline In Vitro Increases following Drug Withdrawal. Antimicrobial Agents and Chemotherapy. 50(3). 922–927. 22 indexed citations

17.

Burker, Eileen J., et al.. (2001). Quality of Life in Patients Awaiting Lung Transplant: Cystic Fibrosis Versus Other End-Stage Lung Diseases.. Cardiopulmonary Physical Therapy Journal. 12(2). 57–57. 1 indexed citations

18.

Hopper, John L., et al.. (1995). Bone density determinants in elderly women: A twin study. Journal of Bone and Mineral Research. 10(11). 1607–1613. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact